Differences in Anxiety, Depression According to Current and Former Smoking Status
Both stable current smokers and individuals who had quit exhibited significantly less anxiety but more depression.
All articles by Sheila Jacobs
COPD Maintenance Therapy: Adverse Outcomes With Tiotropium/Olodaterol vs LABA/ICS
In patients with COPD, tiotropium/olodaterol was associated with a lower risk for escalation to triple therapy or the development of adverse outcomes compared with LABA/ICS.
High PUFAs May Slow Emphysema Progression, Lower Pulmonary Disease Risk
High plasma omega-3 polyunsaturated fatty acid levels have been shown to be associated with a slower progression of percent emphysema.
Asthma-COPD Overlap May Be Independent Risk Factor for Lung Cancer
Patients with asthma-chronic obstructive pulmonary disease overlap may have an increased independent risk for lung cancer that is similar to those with COPD, but higher than smokers with asthma and normal spirometry values.
E-Cigarette and Vaping-Associated Lung Injuries May Have Been Overlooked in the Past
Cases of e-cigarette or vaping product use–associated lung injury (EVALI) appear to have been overlooked in the past.
BMI, Changes in Weight Linked to Mortality in Fibrotic Interstitial Lung Disease
Both body mass index and changes in weight have been linked to 1-year mortality risk in patients with fibrotic interstitial lung disease.
Assessing Biologic Therapy in Asthma With/Without CRS in a Real-World Setting
In a real-world setting, biologic agents offered diverse clinical benefits in patients with asthma with and without chronic rhinosinusitis.
Omalizumab Improves CRS With Nasal Polyps, Regardless of Asthma Status
In patients with chronic rhinosinusitis with nasal polyps, regardless of their asthma status, omalizumab was associated with improvements in nasal polyps score, nasal congestion score, and sinonasal outcome test score.
